KMT2D暂时激活神经元转录因子基因,以调解小脑颗粒细胞分化
Shilpa S Dhar1, Kyung-Pil Ko2, Jinho Jang2
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Science advances
|September 26, 2025
概括
氨酸甲基转移酶KMT2D (MLL4) 对于小脑颗粒细胞 (GC) 的分化至关重要. 它的缺失会扰乱神经元的发育,影响GC的祖先和小鼠的整体大脑结构.
科学领域:
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 发展生物学 发展生物学
背景情况:
- 时间空间基因表达驱动细胞分化,特别是在神经元.
- 在体内控制神经元分化的表观遗传机制尚未完全理解.
- 颗粒细胞 (GCs) 是小脑中最丰富的神经元.
研究的目的:
- 研究KMT2D (MLL4) 在小脑颗粒细胞分化中的表观遗传作用.
- 在体内神经元分化过程中阐明时空基因调节的机制.
主要方法:
- 在小脑GC谱系中使用了Kmt2d的Atoh1-Cre介导淘汰 (ACKO).
- 分析了对小鼠GC原始转换,小脑发育和相关行为的影响.
主要成果:
- Kmt2d ACKO 抑制了 GC 先生的转变为 GC,影响其他小脑细胞.
- 缺乏Kmt2d导致小脑相关行为障碍,面部异常,小头症和体型缩小.
- 发现KMT2D通过超级增强器/增强器编程暂时激活神经元分化程序,包括En2,Pax6和Myt1l等关键转录因子.
结论:
- KMT2D在编排大脑小脑GC分化基因表达方面发挥着至关重要的作用.
- 该研究揭示了一种新的表观遗传机制,涉及神经元发育中的KMT2D介导增强器编程.
更多相关视频
相关概念视频
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
General Transcription Factors
6.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.7K
Forced Transdifferentiation
2.3K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.3K
M-Cdk Drives Transition Into Mitosis
6.3K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.3K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


